Realizing the value of complex medical technology: Demonstrating cost-effectiveness is not enough

被引：0

作者：

Hehakaya, C. ^{[1
]}

Frederix, G. W. J. ^{[2
]}

van Zyp, J. R. N. van der Voort ^{[3
]}

Grobbee, D. E. ^{[1
,3
]}

Verkooijen, H. M. ^{[3
,4
]}

机构：

[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Global Publ Hlth & Bioeth, Utrecht, Netherlands

[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Hlth Econ Evaluat, Utrecht, Netherlands

[3] Univ Med Ctr Utrecht, Div Imaging & Oncol, Utrecht, Netherlands

[4] Univ Utrecht, Utrecht, Netherlands

来源：

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY | 2023年 / 41卷

关键词：

Technologies; Innovations; Implementation; Stakeholders; Complex interventions; Evaluation; CONVERGENT INNOVATION; HEALTH-CARE; RADIOTHERAPY;

D O I：

10.1016/j.ctro.2023.100644

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The main factors driving the value of medical treatments are proven effectiveness and cost-effectiveness. This is different for complex medical technologies that combine scientific disciplines, functions or tools in a single solution-oriented method. This short communication provides three recommendations to realize the value of complex medical technologies. It is important to engage stakeholders before technology implementation to promote its relevance from multiple perspectives, to explore opportunities for professional development and collaboration, and to demonstrate the societal effects over the entire life-cycle.

引用

页数：3

共 50 条

[31] The cost-effectiveness of technology transfer using telemedicine
Johnston, K
Kennedy, C
Murdoch, I
Taylor, P
Cook, C
HEALTH POLICY AND PLANNING, 2004, 19 (05) : 302 - 309
[32] The role of medical necessity and cost-effectiveness in making medical decisions
Glassman, PA
Model, KE
Kahan, JP
Jacobson, PD
Peabody, JW
ANNALS OF INTERNAL MEDICINE, 1997, 126 (02) : 152 - 156
[33] A cceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold
Griffiths, Elizabeth A.
Hendrich, Janek K.
Stoddart, Samuel D. R.
Walsh, Sean C. M.
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 463 - 476
[34] THE CHALLENGES IN EVALUATING THE COST-EFFECTIVENESS OF COMPLEX INTERVENTIONS
Faria, B.
Weatherly, H.
Kiss, N.
Manca, A.
Parker, G.
Beresford, B.
Pilkington, G.
Fawcett, Laver A. J.
Kanaan, M.
Rabiee, P.
Mann, R.
Aspinal, F.
VALUE IN HEALTH, 2015, 18 (07) : A727 - A728
[35] Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review
William V. Padula
Hui-Han Chen
Charles E. Phelps
Applied Health Economics and Health Policy, 2021, 19 : 155 - 162
[36] Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review
Padula, William, V
Chen, Hui-Han
Phelps, Charles E.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2021, 19 (02) : 155 - 162
[37] Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI)
Barton, Garry R.
Briggs, Andrew H.
Fenwick, Elisabeth A. L.
VALUE IN HEALTH, 2008, 11 (05) : 886 - 897
[38] VALUE AND COST CONUNDRUM IN ADVANCED ONCOLOGY: INTEGRATION OF VALUE FRAMEWORKS INTO COST-EFFECTIVENESS ANALYES
Ambavane, A.
Benedict, A.
Lanitis, T.
Kongnakorn, T.
VALUE IN HEALTH, 2016, 19 (07) : A399 - A399
[39] Generalized cost-effectiveness analysis: charting a path forward for measuring the societal value of medical technologies
Li, Meng
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2025, 14 (01)
[40] VALUE-BASED PRICING SCHEME FOR NEW TECHNOLOGY IN CONSIDERATION OF COST-EFFECTIVENESS DOMINANCE TO THE CONTROL
Kamae, I
Sugimoto, T.
Yamabe, K.
VALUE IN HEALTH, 2015, 18 (07) : A732 - A732

← 1 2 3 4 5 →